1Gregory J,Randall TH,Anthony JF, et al . Proct : A Phase Ⅱ Randomized Trial of recombinant pro-Urokinade by directarterial delivery in acute middle cereberal artery stroke [J]. Stroke, 1998,29: 4-11.
2Bendszus M,Urbach H,Ries F, et al . Outcome after local in traarterial fibrinolysis compared with the natural course of pa tients with a dense middle cerebral artery on early CT [J]. Neuroradiology, 1998,40 :54-58.
3Bourekas E,Slivka A. Intraarterial thrombolytic therapy within 3 hours of the onset of stoke[J]. Neurosurgery,2004, 54: 39- 46.
4Kidwell CS,Saver JL, Carneado J, et al. Predictors of hemorrhagic transformation in patients receiving intraarterial thrombolysis[J]. Stroke, 2002, 33: 717-724.
5Barr JD.Cerebral angiography in the assessment of acute cerebral ischemia:guidelines and recommendations.J Vasc Interv Radiol,2004,15:S57-66.
6Hacke W,Kaste M,Bluhmki E,et al.Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke.N Engl J Med,2008,359:1317-1329.
7The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group.Tissue plasminogen activator for acute ischemic stroke.N Engl J Med,1995,333:1581-1587.
8Hacke W,Kaste M,Fieschi C,et al.Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke:the European Cooperative Acute Stroke Study (ECASS).JAMA,1995,274:1017-1025.
9Hacke W,Kaste M,Fieschi C,et al.Second EuropeanAustralasian Acute Stroke Study Investigators.Randomised doubleblind placebo-controlled trial of thrombolytic therapy with intravenous aheplase in acute ischaemic stroke (ECASS Ⅱ).Lancet,1998,352:1245-1251.
